Therapeutic Potential of Harmala (Peganum harmala L.) Seeds with an Array of Pharmacological Activities
- 1 January 2011
- book chapter
- Published by Elsevier BV
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cellsNutrition Research and Practice, 2010
- Antiplatelet activity of β-carboline alkaloids from Perganum harmala: A possible mechanism through inhibiting PLCγ2 phosphorylationVascular Pharmacology, 2009
- Isolation of Betulinic Acid, its Methyl Ester and Guaiane Sesquiterpenoids with Protein Tyrosine Phosphatase 1B Inhibitory Activity from the Roots of Saussurea lappa C.B.ClarkeMolecules, 2009
- Effect ofPeganum harmalaor itsβ-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultryPhytotherapy Research, 2008
- A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extractForensic Science International, 2008
- The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitorsBioorganic & Medicinal Chemistry, 2008
- Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activitiesJournal of Natural Medicines, 2008
- Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: Possible mechanisms involvedJournal of Ethnopharmacology, 2008
- Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seed's in isolated rat aortaPharmacological Research, 2006
- Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agentPhytochemistry, 2005